• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首个用于校准商业免疫分析的经过认证的β淀粉样蛋白 1-42 参考物质。

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays.

机构信息

European Commission, Joint Research Centre (JRC), Geel, Belgium.

Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden.

出版信息

Alzheimers Dement. 2020 Nov;16(11):1493-1503. doi: 10.1002/alz.12145. Epub 2020 Aug 4.

DOI:10.1002/alz.12145
PMID:32755010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7984389/
Abstract

INTRODUCTION

Reference materials based on human cerebrospinal fluid were certified for the mass concentration of amyloid beta (Aβ)1-42 (Aβ ). They are intended to be used to calibrate diagnostic assays for Aβ .

METHODS

The three certified reference materials (CRMs), ERM-DA480/IFCC, ERM-DA481/IFCC and ERM-DA482/IFCC, were prepared at three concentration levels and characterized using isotope dilution mass spectrometry methods. Roche, EUROIMMUN, and Fujirebio used the three CRMs to re-calibrate their immunoassays.

RESULTS

The certified Aβ mass concentrations in ERM-DA480/IFCC, ERM-DA481/IFCC, and ERM-DA482/IFCC are 0.45, 0.72, and 1.22 μg/L, respectively, with expanded uncertainties (k = 2) of 0.07, 0.11, and 0.18 μg/L, respectively. Before re-calibration, a good correlation (Pearson's r > 0.97), yet large biases, were observed between results from different commercial assays. After re-calibration the between-assay bias was reduced to < 5%.

DISCUSSION

The Aβ CRMs can ensure the equivalence of results between methods and across platforms for the measurement of Aβ .

摘要

简介

基于人脑脊液的参考物质已通过认证,可用于测定淀粉样蛋白β(Aβ)1-42(Aβ)的质量浓度。这些参考物质旨在用于校准 Aβ 的诊断检测。

方法

三个经过认证的参考物质(CRM),ERM-DA480/IFCC、ERM-DA481/IFCC 和 ERM-DA482/IFCC,在三个浓度水平下制备,并使用同位素稀释质谱法进行了特征描述。罗氏、EUROIMMUN 和富士瑞必欧利用这三种 CRM 重新校准了他们的免疫测定法。

结果

ERM-DA480/IFCC、ERM-DA481/IFCC 和 ERM-DA482/IFCC 中认证的 Aβ 质量浓度分别为 0.45、0.72 和 1.22μg/L,扩展不确定度(k=2)分别为 0.07、0.11 和 0.18μg/L。在重新校准之前,不同商业检测方法之间的结果相关性很好(Pearson's r>0.97),但存在较大的偏倚。经过重新校准,检测之间的偏倚降低到<5%。

讨论

Aβ CRM 可确保方法之间以及不同平台之间 Aβ 测量结果的等效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/8be604983600/ALZ-16-1493-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/43720099bc78/ALZ-16-1493-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/f9e08fa07139/ALZ-16-1493-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/8a4e68bff38d/ALZ-16-1493-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/b550e3015a80/ALZ-16-1493-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/8be604983600/ALZ-16-1493-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/43720099bc78/ALZ-16-1493-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/f9e08fa07139/ALZ-16-1493-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/8a4e68bff38d/ALZ-16-1493-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/b550e3015a80/ALZ-16-1493-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f96/7984389/8be604983600/ALZ-16-1493-g001.jpg

相似文献

1
First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays.首个用于校准商业免疫分析的经过认证的β淀粉样蛋白 1-42 参考物质。
Alzheimers Dement. 2020 Nov;16(11):1493-1503. doi: 10.1002/alz.12145. Epub 2020 Aug 4.
2
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements.用于标准化人脑脊液中β-淀粉样蛋白 1-42 测定的认证参考物质的可互换性:对 tau 和β-淀粉样蛋白 1-40 测量的启示。
Clin Chem Lab Med. 2018 Nov 27;56(12):2058-2066. doi: 10.1515/cclm-2018-0147.
3
Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS.Elecsys®β-淀粉样蛋白(1-42)脑脊液测定与比较测定和 LC-MS/MS 的方法比较研究。
Clin Biochem. 2019 Oct;72:7-14. doi: 10.1016/j.clinbiochem.2019.05.006. Epub 2019 May 23.
4
Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.基于质谱的脑脊液中淀粉样β蛋白定量候选参考测量程序。
Clin Chem. 2014 Jul;60(7):987-94. doi: 10.1373/clinchem.2013.220392. Epub 2014 May 19.
5
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.评估参考物质格式的可互换性,以实现淀粉样蛋白-β测量的协调一致。
Clin Chem Lab Med. 2016 Jul 1;54(7):1177-91. doi: 10.1515/cclm-2015-0733.
6
Characterization of the new serum protein reference material ERM-DA470k/IFCC: value assignment by immunoassay.新型血清蛋白参考物质 ERM-DA470k/IFCC 的特征描述:免疫测定赋值。
Clin Chem. 2010 Dec;56(12):1880-8. doi: 10.1373/clinchem.2010.148809. Epub 2010 Oct 5.
7
First certified reference material for cystatin C in human serum ERM-DA471/IFCC.人血清胱抑素 C 参考物质 ERM-DA471/IFCC 的首次认证。
Clin Chem Lab Med. 2010 Nov;48(11):1619-21. doi: 10.1515/CCLM.2010.318. Epub 2010 Oct 29.
8
Certification of Amyloid-Beta (Aβ) Certified Reference Materials by Amino Acid-Based Isotope Dilution High-Performance Liquid Chromatography Mass Spectrometry and Sulfur-Based High-Performance Liquid Chromatography Isotope Dilution Inductively Coupled Plasma Mass Spectrometry.基于氨基酸的同位素稀释高效液相色谱-质谱联用和基于硫的高效液相色谱-同位素稀释电感耦合等离子体质谱联用对β-淀粉样蛋白(Aβ)标准物质的认证
Anal Chem. 2020 Oct 6;92(19):13229-13237. doi: 10.1021/acs.analchem.0c02381. Epub 2020 Sep 10.
9
Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.不同淀粉样蛋白免疫测定法与视觉淀粉样蛋白正电子发射断层扫描评估之间的一致性
JAMA Neurol. 2017 Dec 1;74(12):1492-1501. doi: 10.1001/jamaneurol.2017.2814.
10
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.采用质谱法对脑脊液中淀粉样蛋白-β 1-42 进行定量的轮次测试。
Alzheimers Dement. 2016 Jan;12(1):55-9. doi: 10.1016/j.jalz.2015.06.1890. Epub 2015 Jul 21.

引用本文的文献

1
Development of amyloid β (1-42) certified reference material NMIJ CRM 6210-a.β-淀粉样蛋白(1-42)有证参考物质NMIJ CRM 6210-a的研制。
Anal Bioanal Chem. 2025 May;417(12):2679-2689. doi: 10.1007/s00216-025-05797-0. Epub 2025 Mar 5.
2
Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice.阿尔茨海默病诊断与分期修订标准的应用:药物研发与临床实践
Alzheimers Dement (N Y). 2024 Dec 14;10(4):e70013. doi: 10.1002/trc2.70013. eCollection 2024 Oct-Dec.
3
Analytical and clinical performance of eight Simoa and Lumipulse assays for automated measurement of plasma p-tau181 and p-tau217.

本文引用的文献

1
Towards a unified protocol for handling of CSF before β-amyloid measurements.建立用于β-淀粉样蛋白检测前脑脊液处理的统一方案。
Alzheimers Res Ther. 2019 Jul 19;11(1):63. doi: 10.1186/s13195-019-0517-9.
2
Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.载脂蛋白 E ε4 对前驱期阿尔茨海默病的神经影像学、脑脊液生物标志物和认知的影响。
Neurobiol Aging. 2018 Nov;71:81-90. doi: 10.1016/j.neurobiolaging.2018.07.003. Epub 2018 Jul 11.
3
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements.
八种用于自动检测血浆p-tau181和p-tau217的Simoa和Lumipulse检测方法的分析性能和临床性能
Alzheimers Res Ther. 2024 Dec 19;16(1):266. doi: 10.1186/s13195-024-01630-5.
4
ADNI Biomarker Core: A review of progress since 2004 and future challenges.ADNI生物标志物核心:2004年以来的进展回顾与未来挑战
Alzheimers Dement. 2025 Jan;21(1):e14264. doi: 10.1002/alz.14264. Epub 2024 Nov 30.
5
Evaluation of the EUROIMMUN automated chemiluminescence immunoassays for measurement of four core biomarkers for Alzheimer's disease in cerebrospinal fluid.评估EUROIMMUN自动化学发光免疫分析法用于测量脑脊液中阿尔茨海默病四种核心生物标志物的性能。
Pract Lab Med. 2024 Sep 5;41:e00425. doi: 10.1016/j.plabm.2024.e00425. eCollection 2024 Aug.
6
Contributions of the ADNI Biostatistics Core.ADNI 生物统计学核心的贡献。
Alzheimers Dement. 2024 Oct;20(10):7331-7339. doi: 10.1002/alz.14159. Epub 2024 Aug 14.
7
Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting.阿尔茨海默病血液生物标志物:研究设计、样本采集、处理、生物样本库、测量和结果报告的实用指南。
Mol Neurodegener. 2024 May 15;19(1):40. doi: 10.1186/s13024-024-00711-1.
8
An LC-MS/MS-based platform for the quantification of multiple amyloid beta peptides in surrogate cerebrospinal fluid.一种基于液相色谱-串联质谱的平台,用于定量替代脑脊液中的多种β淀粉样肽。
J Mass Spectrom Adv Clin Lab. 2024 Jan 22;31:40-48. doi: 10.1016/j.jmsacl.2024.01.002. eCollection 2024 Jan.
9
Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer's disease diagnosis.用于阿尔茨海默病诊断的全合成磷酸化Tau181、Tau217和Tau231校准品。
Front Aging Neurosci. 2024 Jan 15;15:1340706. doi: 10.3389/fnagi.2023.1340706. eCollection 2023.
10
Alzheimer's Disease Biomarker Analysis Using Targeted Mass Spectrometry.采用靶向质谱分析法对阿尔茨海默病的生物标志物进行分析。
Mol Cell Proteomics. 2024 Feb;23(2):100721. doi: 10.1016/j.mcpro.2024.100721. Epub 2024 Jan 20.
用于标准化人脑脊液中β-淀粉样蛋白 1-42 测定的认证参考物质的可互换性:对 tau 和β-淀粉样蛋白 1-40 测量的启示。
Clin Chem Lab Med. 2018 Nov 27;56(12):2058-2066. doi: 10.1515/cclm-2018-0147.
4
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.阿尔茨海默病的脑脊液生物标志物与淀粉样蛋白-β PET 一致,并可预测临床进展:在 BioFINDER 和 ADNI 队列中使用全自动免疫分析的研究。
Alzheimers Dement. 2018 Nov;14(11):1470-1481. doi: 10.1016/j.jalz.2018.01.010. Epub 2018 Mar 1.
5
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.载脂蛋白 E ε4 对脑脊液 Aβ42 浓度的临床前作用。
Alzheimers Res Ther. 2017 Oct 23;9(1):87. doi: 10.1186/s13195-017-0313-3.
6
How to handle adsorption of cerebrospinal fluid amyloid β (1-42) in laboratory practice? Identifying problematic handlings and resolving the issue by use of the Aβ/Aβ ratio.在实验室实践中如何处理脑脊液淀粉样蛋白β(1-42)的吸附?通过使用 Aβ/Aβ 比值来识别有问题的处理方法并解决该问题。
Alzheimers Dement. 2017 Aug;13(8):885-892. doi: 10.1016/j.jalz.2017.01.010. Epub 2017 Feb 21.
7
Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes.使用低蛋白结合管分析脑脊液Aβ42及Aβ亚型比值的优化标准操作规程
J Alzheimers Dis. 2016 May 31;53(3):1121-32. doi: 10.3233/JAD-160286.
8
CSF Aβ - an excellent but complicated Alzheimer's biomarker - a route to standardisation.脑脊液淀粉样蛋白β——一种出色但复杂的阿尔茨海默病生物标志物——标准化之路。
Clin Chim Acta. 2017 Apr;467:27-33. doi: 10.1016/j.cca.2016.05.014. Epub 2016 May 20.
9
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid.一种新型全自动电化学发光免疫分析法检测人脑脊液中β-淀粉样蛋白(1-42)的技术性能。
Alzheimers Dement. 2016 May;12(5):517-26. doi: 10.1016/j.jalz.2015.09.009. Epub 2015 Nov 10.
10
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.评估参考物质格式的可互换性,以实现淀粉样蛋白-β测量的协调一致。
Clin Chem Lab Med. 2016 Jul 1;54(7):1177-91. doi: 10.1515/cclm-2015-0733.